Societal CDMO to Report Financial Results for First Quarter 2022 on May 11, 2022
04 mai 2022 16h05 HE
|
Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., May 04, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL), a contract development and manufacturing organization (CDMO)...
Global Pharmaceutical Contract Manufacturing Market Report 2022: Market to Reach $130.2 Billion by 2026 - Emergence of Outsourcing Trend Bodes Well for CDMOs
03 mai 2022 05h23 HE
|
Research and Markets
Dublin, May 03, 2022 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Manufacturing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global...
Societal CDMO Secures Manufacturing and Packaging Task Order Award from National Cancer Institute (NCI)
27 avr. 2022 07h00 HE
|
Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., April 27, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to...
Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Markets, Analysis & Forecasts 2016-2021, 2021-2026F, 2031F
11 avr. 2022 04h53 HE
|
Research and Markets
Dublin, April 11, 2022 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Development And Manufacturing Organization (CMO) Global Market Report 2022: By Type, By Research, By End-User" report has been...
Societal CDMO Reports Inducement Grants for New Staff
06 avr. 2022 16h05 HE
|
Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., April 06, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to...
Allergy Therapeutics Selects AGC Biologics to Manufacture Novel Peanut Allergy Vaccine Candidate
31 mars 2022 09h00 HE
|
AGC Biologics
Seattle, March 31, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a new partnership with...
ProPhase Labs to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call on Wednesday, March 30, 2022 at 11:00 a.m. Eastern Time
24 mars 2022 08h15 HE
|
ProPhase Labs, Inc.
GARDEN CITY, NY, March 24, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified company offering a range of services including diagnostic testing, genomics testing and contract...
Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Outlook Report 2022: Growing Need for High Potency Active Pharmaceutical Ingredients (HPAPI) - Forecast to 2030
24 mars 2022 06h38 HE
|
Research and Markets
Dublin, March 24, 2022 (GLOBE NEWSWIRE) -- The "Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Outlook 2020-2030" report has been added to...
Recro Announces Name Change to Societal CDMO to Reflect Corporate Expansion and Transformation
21 mars 2022 07h00 HE
|
Recro Pharma, Inc.
With Expanded Industry Expertise, Enhanced Service Offerings and Bi-Coastal Operations, Company Now Optimally Positioned to Support Customers’ Goal of Delivering Impactful Medicines to SocietyNew...
Avid Bioservices to Participate in KeyBanc Capital Markets Life Sciences & MedTech Forum
16 mars 2022 16h05 HE
|
Avid Bioservices, Inc
TUSTIN, Calif., March 16, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...